Dr. Yehuda Lebowicz MD

Media Releases

Get to know Hematologist and Oncologist Dr. Yehuda Lebowicz, who serves the population of New York. Board certified and Fellowship trained Dr. Lebowicz currently practices as a Hematologist and Oncologist with Edwards Comprehensive Cancer Center, as well as an Assistant Professor with Marshall University. The staff of the Medical Oncology Program at the Edwards Comprehensive Cancer Center is committed to improving the diagnosis and treatment of adult patients with cancer. Medical oncologists, physicians with special training and experience in diagnosis and treatment of a wide spectrum of malignant diseases, plan cancer treatments involving the use of chemotherapy, hormonal agents and/or biological therapy in the management of cancer. At the Edwards Comprehensive Cancer Center, medical oncologists care for their patients from diagnosis throughout the course of the disease by educating patients about their cancer and the stages of its development, discussing treatment options and making recommendations and monitoring the care and treatment of the patient. Dr. Lebowicz graduated with his Medical degree from the State University of New York at Stony Brook School of Medicine in 2002, giving him over two decades of experience in his field. After obtaining his medical degree he completed his residency and fellowship with the Long Island Jewish Medical Center. Dr. Lebowicz is dual-certified in Medical Oncology and Hematology by the American Board of Internal Medicine. Since its founding in 1936 to answer a public call to establish more uniform standards for physicians, Certification by the American Board of Internal Medicine (ABIM) has stood for the highest standard in internal medicine and its 20 subspecialties. Certification has meant that internists have demonstrated – to their peers and to the public – that they have the clinical judgment, skills and attitudes essential for the delivery of excellent patient care. To stay up to date in his field, he remains a professional member of the American Medical Association, American Society of Clinical Oncology, American Society of Hematology, Alpha Omega Alpha Honor Medical Society, Alliance for Academic Internal Medicine, and the Association of Program Directors in Internal Medicine.

Recommended Articles

• How Dogs Are Helping with Lymphoma Research

  According to the Cornell Chronicle (CC), Cornell and Tufts University have received a huge grant for the study of human lymphoma, using a humane approach to test on dogs.The dogs in the study will already have lymphoma and it’s hoped they’ll be cured in the process of this research study.There...

• New Study Discovers How Lymphoma Affects Survivors’ Ability to Work

  Young adults in many countries pride themselves on their work. They have worked hard to get to where they are and there is a huge sense of accomplishment in joining the adult world and being able to provide for themselves and their new families if applicable. When cancer comes along, their ability...

• What Specialists Treat Multiple Myeloma?

  If you suffer from multiple myeloma, which a rare form of blood cancer, one of the most crucial decisions you will have to make is choosing a doctor who specializes in multiple myeloma. A hematologist-oncologist is the specialist you need who will manage your cancer throughout the cycle of...

• John Quinones Teams Up With Survivors For Leukemia and Lymphoma Society

  Many cancer patients suffer in silence, with the public being largely unaware of the different types of cancer and how they affect patients. Most people obviously know that cancer is well, a bad thing, but there is a lot of nuance and important information that is lost on the common citizen. Most...

• The Lymphoma Research Foundation's Light it Red for Lymphoma Night

  Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...

• Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients

  Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...